Details:
Dexa Medica’s nation-wide launch and distribution of triptorelin, as Debiopharm’s exclusive Indonesian licensee, will help patients in the region gain access to the pain-relieving benefits of hormone suppression with Pamorelin®.
Lead Product(s): Triptorelin Pamoate
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Pamorelin
Highest Development Status: Approved Product Type: Large molecule
Partner/Sponsor/Collaborator: Debiopharm
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration October 07, 2021